Search - tctmd.com

Displaying 1 - 20 of 292

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1282: Artificial Intelligence–Derived Fractional Flow Reserve in Routine Clinical Practice: An International Multicenter Retrospective Study

Presenter: Eyal Ben-Assa

October 27, 2025

Presentation TCT 2025

TCT 456: Sex Bias in Clinical Prediction Models

Presenter: Larissa Stanberry

October 27, 2025

Presentation TCT 2025

Percutaneous Coronary Angioplasty Versus Coronary Artery Bypass Grafting in the Treatment of Unprotected Left Main Stenosis: 10-year Mortality Outcomes from the Randomized NOBLE Trial

Presenter: Evald H. Christiansen

October 27, 2025

Presentation TCT 2025

Drug-Coated Balloon Angioplasty with Rescue Stenting Versus Intended Stenting for the Treatment of DeNovo Coronary Artery Lesions: 3-Year Clinical Outcomes of the REC-CAGEFREE I Trial

Presenter: Chao Gao

October 27, 2025

Presentation TCT 2025

TCT 447: Invisible Hearts: The Underrepresentation of Women in Cardiovascular Clinical Trials

Presenter: Pablo Juan Salvadores

October 27, 2025

Presentation TCT 2025

Sirolimus-Eluting Iron Bioresorbable Scaffold in Coronary Artery Disease: Two-Year Results of IRONMAN-II Randomized Controlled Trial

Presenter: Lei Song

October 27, 2025

Presentation TCT 2025

Comparison of Drug-Coated Versus Conventional Balloons for Treatment of Side Branches of Bifurcation Lesions: The OCVC-BIF Study

Presenter: Takayuki Ishihara

October 27, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Presentation TCT 2025

TCT 445: Diagnostic Coronary Angiography Performed with a Novel Miniaturized Robotic System: A Pre-Clinical Feasibility Study

Presenter: Nicholas Mitchell

October 26, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

August 13, 2025

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

News Daily News

HOPE Supports IV Alteplase in Late Window After Acute Ischemic Stroke

August 11, 2025

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

News Daily News

Oral GLP-1 Drug Yields 12% Weight Loss in Nondiabetic Patients With Obesity

August 07, 2025

Self-service Kiosks May Aid Population Monitoring of High BP

News Daily News

Self-service Kiosks May Aid Population Monitoring of High BP

August 07, 2025

US Stroke Rehab System Not Serving Patient Needs, Societies Say

News Daily News

US Stroke Rehab System Not Serving Patient Needs, Societies Say

August 07, 2025

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

Frail Older Patients With AF May Fare Better Switching to DOAC

News Daily News

Frail Older Patients With AF May Fare Better Switching to DOAC

August 05, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

News Daily News

Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT

Michael O'Riordan

July 31, 2025

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

News Daily News

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

July 31, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.